Upcoming event

Metastatic Prostate Cancer


This recorded webinar will comprise three presentations that provide comprehensive state-of-the-art information on currently available therapies for hormone-naïve prostate cancer (HNPC) and castration-resistant prostate cancer (CRPC).

The therapies will include androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPI), chemotherapy, radioligand, and poly (ADP-ribose) polymerase (PARP) inhibitors.

The recorded webinar aims to enable participants in optimising treatment combinations and sequences in metastatic prostate cancer at all disease stages.

Prof. B. Tombal (BE)
Dr. C. Thibault (FR)
Prof. Dr. C. Gratzke (DE)